Retour
Fourchette du Jour
58,01 €
58,01 €
Fourchette 52 Semaines
5,67 €
58,02 €
Volume
10 846 697
Moyenne 50J / 200J
49,05 €
/
26,91 €
Clôture Précédente
58,01 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,4 | 0,3 |
| P/B | 5,1 | 3,0 |
| ROE % | -77,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
60,00 €
+3.4%
Low: 58,00 €
High: 70,00 €
BPA Prévisionnel
-3,17 €
CA Est.
10,19M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-6,47 €
-6,47 € – -6,47 €
|
18,15M | 1 |
| FY2028 |
-4,80 €
-5,55 € – -3,92 €
|
83,70M | 3 |
| FY2027 |
-3,71 €
-4,55 € – -3,15 €
|
805 355,0 | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | -0,82 € | -9,12 € | -1008,2% |
| 2025-11-06 | -0,88 € | -0,65 € | +26,1% |
| 2025-08-07 | -0,61 € | -0,65 € | -6,6% |
| 2025-05-08 | -2,48 € | -0,64 € | +74,2% |
| 2025-03-06 | -0,45 € | -1,14 € | -153,3% |
| 2024-11-12 | -0,56 € | -0,47 € | +16,1% |
| 2024-08-08 | -0,74 € | -0,71 € | +4,1% |
| 2024-05-09 | -0,78 € | -0,79 € | -1,3% |
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -83,42M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-77,09%
ROIC-52,51%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,02
Current Ratio4,87
Interest Coverage0,00
Valorisation
P/E Ratio
-7,39
Forward P/EN/A
P/B Ratio5,05
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -129,87M |
| ROE | -77,09% | ROA | -54,04% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -83,42M |
| ROIC | -52,51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,87 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,39 | Forward P/E | N/A |
| P/B Ratio | 5,05 | P/S Ratio | N/A |
| PEG Ratio | -0,11 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,70% | ||
| Market Cap | 959,26M | Enterprise Value | 794,01M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 1,53M | 3,81M | 5,04M |
| Net Income | -129,87M | -116,80M | -83,84M | -69,20M | -52,89M |
| EPS (Diluted) | -25,49 | -24,37 | -20,61 | -20,21 | -17,53 |
| Gross Profit | 0,0 | 0,0 | 1,53M | 3,81M | 5,04M |
| Operating Income | -136,10M | -127,06M | -85,80M | -69,21M | -53,21M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 240,33M | 173,33M | 266,21M | 198,64M | 118,97M |
| Total Liabilities | 50,42M | 26,29M | 21,04M | 12,26M | 14,79M |
| Shareholders' Equity | 189,90M | 147,04M | 245,17M | 186,38M | 104,18M |
| Total Debt | 4,49M | 6,91M | 8,99M | 0,0 | 0,0 |
| Cash & Equivalents | 169,74M | 47,48M | 38,95M | 24,03M | 24,92M |
| Current Assets | 235,24M | 161,78M | 252,69M | 192,97M | 115,60M |
| Current Liabilities | 48,35M | 21,84M | 14,22M | 9,60M | 11,74M |